Psychedelics The revolutionary drugs that could change your life--a guide from the expert

David J. Nutt, 1951-

Book - 2024

"We are on the cusp of a major revolution in psychiatric medicine and neuroscience. After fifty years of prohibition, criminalization and fear, science is finally showing us that psychedelics are not dangerous or harmful. Instead, when used according to tested, safe and ethical guidelines, they are our most powerful newest treatment of mental health conditions, from depression, PTSD, and OCD to disordered eating and even addiction and chronic pain. Professor David Nutt, one of the world's leading Neuropsychopharmacologists, has spent 15 years researching this field and it is his most significant body of work to date. In 2018, he co-founded the first academic psychedelic research center--underpinned by his mission to provide eviden...ce-based information for people everywhere. It revived interest in the understanding and use of this drug in its many forms, including MDMA, ayahuasca, magic mushrooms, LSD and ketamine. The results of this have been nothing short of ground-breaking for the future categorization of drugs, but also for what we now know about brain mechanisms and our consciousness. At a time where there is an enormous amount of noise around the benefits of psychedelics, this book contains the knowledge you need to know about a drug that is about to go mainstream, free from the hot air, direct from the expert."--Amazon.com.

Saved in:

2nd Floor New Shelf Show me where

615.7883/Nutt
1 / 1 copies available
Location Call Number   Status
2nd Floor New Shelf 615.7883/Nutt (NEW SHELF) Checked In
Subjects
Genres
Informational works
Published
New York : Hachette Go 2024.
Language
English
Main Author
David J. Nutt, 1951- (author)
Other Authors
Brigid Moss (author)
Edition
First edition
Physical Description
vii, 328 pages : illustrations ; 23 cm
Bibliography
Includes bibliographical references and index.
ISBN
9780306835285
  • Introduction
  • Chapter 1. Why Psychedelics Are Back
  • Chapter 2. What is a Psychedelic? Meet the Classics: LSD, Magic Mushrooms, Ayahuasca
  • Chapter 3. An Introduction to the Non-Classics: MDMA, Ketamine, Ibogaine
  • Chapter 4. What Happens in Your Brain During a Trip?
  • Chapter 5. Can Psychedelics Treat Depression?
  • Chapter 6. The History and Practice of Psychedelic Therapy
  • Chapter 7. Can Psychedelics Treat Dependence?
  • Chapter 8. MDMA: PTSD, Trauma and Relationships
  • Chapter 9. End of Life, Mystical Experiences and Finding God
  • Chapter 10. Classic Psychedelics: Anxiety, Pain, Eating Disorders, ADHD and OCD
  • Chapter 11. Microdosing, Midi-Dosing and Macro-Dosing
  • Chapter 12. My Sacking, MDMA and the Real Harm of Drugs
  • Chapter 13. Are Psychedelics Addictive or Dangerous?
  • Conclusion
  • Notes
  • Acknowledgments
  • Index
  • About the Author
Review by Booklist Review

"After 50 years of prohibition, criminalization and stigmatization, science is finally showing that psychedelics are not usually dangerous or harmful," psychiatrist and researcher Nutt proclaims, and postulates that in the coming years the use of certain psychedelic drugs in conjunction with psychotherapy will be a gamechanger for mental health treatment. Nutt describes the effects of "classic" (LSD, psilocybin, ayahuasca) and "non-classic" (MDMA, ketamine) psychedelic substances (including side effects like dizziness and gastrointestinal symptoms), and reviews current research into their mental health benefits when administered in controlled, medical environments. For example, he explains how classic psychedelics can affect perception, mood, and sense of self, triggering spiritual and mystical experiences by sparking neuroplasticity and generating new neural connections. Non-classics are already on their way to approval: ketamine is available for treatment-resistant depression and MDMA is in trials for treating PTSD. Despite all the misunderstanding and taboo surrounding psychedelics, Nutt ably advocates for their remarkable medicinal benefits.

From Booklist, Copyright (c) American Library Association. Used with permission.